There can be no doubt that cortisone and its analogues have revolutionized the treatment, and to a lesser extent the diagnosis, of endocrine diseases during the last decade. Although available through the pharmaceutical houses in a wide variety of different formulations to meet particular needs, these steroids can be classified into three main groups according to their influence on salt and water and on carbohydrate metabolism:
There can be no doubt that cortisone and its analogues have revolutionized the treatment, and to a lesser extent the diagnosis, of endocrine diseases during the last decade. Although available through the pharmaceutical houses in a wide variety of different formulations to meet particular needs, these steroids can be classified into three main groups according to their influence on salt and water and on carbohydrate metabolism:
(a) Prednisone and prednisolone have for practical purposes in clinical endocrinology no effect on salt and water metabolism, although on a weight for weight basis they are some four or five times more potent than cortisone in their anti-inflammatory and liver glycogen-deposition action. Their failure to influence sodium metabolism makes them of little value in the treatment of endocrine conditions when there is adrenal insufficiency, but enhances their usefulness in the treatment of certain general medical conditions, such as the collagen disorders (see page 322).
(b) Cortisone and hydrocortisone influence both carbohydrate metabolism and, to a lesser extent, the renal excretion of sodium. This makes them particularly valuable as substitution agents in patients with adrenal insufficiency. Weight for weight, cortisone is about four-fifths as potent as hydrocortisone and is converted in the body to hydrocortisone before exerting any physiological action. Cortisone and hydrocortisone are absorbed from the gastro-intestinal tract within an hour, whether administered as the free alcohol or as the acetate ester. Given by intramuscular injection absorption is much slower and more prolonged, and this route is not satisfactory when a rapid response is needed, as in acute adrenal insufficiency. (Beck and Montgomery, 1956 ) have maintained that cortisone alone is adequate replacement in adrenal insufficiency, it has been my experience and that of others (Nabarro and Walker, 1957) that, unless an additional hormone with greater mineralocorticoid activity is given, clinical manifestations of sodium depletion or biochemical abnormalities (a low serum sodium level and sometimes also hypochloraemia and hyperkalaemia) tnay occur, even though supplements of sodium chloride are given. For this reason routine estimation of the blood urea and serum sodium, chloride and potassium levels is necessary. Correction of hypotension or hyponatraemia is best achieved with 9 a-fluorohydrocortisone by mouth. The amount given must be sufficient to achieve normal serum electrolyte levels and not so great as to induce oedema or hypertension (Fig. i) , although it should be remembered that the ' normal ' blood pressure of elderly patients may be greater than the statutory I20/80 mm. Hg, and these patients will feel better when the blood pressure is maintained at 140 to I50/90 mm. Hg. Although some workers have used a compound tablet containing both cortisone and fluorohydrocortisone (Leith and Beck, 1957) , greater flexibility is obtained if the two steroids are given separately. Fluorohydrocortisone is slow in producing its effect and long lasting, so that adjustments in dosage should be made gradually. The individual dose varies, but most patients require O.i mg. every day or on alternate days and some are satisfactorily eontrolled with 0.5 mg. every third day. A careful watch must be kept for the development of oedema or hypertension. Usually these occur together, although Owen and his colleagues (I957), using doses that would now be considered too large, noted hypertension without oedema in some patients and oedema without hypertension in others.
It is now our practice to start replacement therapy in chronic adrenal insufficiency with cortisone and later, after one to two weeks, to add fluorohydrocortisone. Often the addition of the potent mineralocorticoid requires an adjustment in the dose of cortisone (Leith and Beck, 1957) , because to some extent cortisone and fluorohydrocortisone are mutually antagonistic in their actions. In an adrenalectomized patient replacement therapy with fluorohydrocortisone alone readily induces oedema; if cortisone is then given and the dose of fluorohydrocortisone maintained unaltered, the oedema usually subsides (Bayliss, Ig97b).
Thus, in controlling chronic adrenal insufficiency a nice balance between cortisone and fluorohydrocortisone must be achieved. On this regimen-it is not necessary to give additional supplements of sodium chloride.
Acute Adrenal Insufficiency
Depending on the severity of the patient's condition, treatment should be intravenous or by mouth. It is a common mistake to think that an intramuscular injection of cortisone or hydrocortisone will have a more rapid effect than oral treatment. Usually the patient is dehydrated, hypotensive and may also be hypoglycaemic, and the fact that he is vomiting demands intravenous treatment. An infusion of 500 ml. 5 per cent. glucose in saline is set up and ioo mg. hydrocortisone free-alcohol dissolved in 50 per cent. ethanol added to the bottle, or 134 mg. hydrocortisone hemisuccinate dissolved in IO ml. saline injected into the tubing. After two hours the same amount of steroid is given with i 1. of glucose saline. During the first 24 hours 2.5 1. of fluid and 400 mg. hydrocortisone should be infused. If hypotension is not corrected quickly, 2 to 4 mg. nor-adrenaline are added to each bottle of infusion. As soon as clinical improvement allows and vomiting has stopped, cortisone and fluorohydrocortisone are given orally as in chronic adrenal insufficiency. Where the acute adrenal failure is due to a fulminating infection (Waterhouse-Friderichsen syndrorne) the appropriate antibiotic must be given in maximum dosage.
During bilateral adrenalectomy a depot of cortisone is provided by injecting intramuscularly ioo mg. cortisone acetate on the night before and again two hours before the operation. During the operation and for the next 24 hours an infusion of 2 1. of 5 per cent. glucose is given containing 300 to 400 mg. hydrocortisone. During the next 24 hours two intramuscular injections of ioo mg. cortisone are given and then 50 mg. cortisone six-hourly by mouth for 48 hours. The dosage is gradually reduced over the next seven days until maintenance therapy with I2.5 mg. six-hourly is being given. At this time fluorohydrocortisone is added. As in acute adrenal insufficiency, nor-adrenaline is infused over the operation period if the systolic blood pressure falls below ioo mm. Hg.
Panhypopituitarism
Although the clinical picture of panhypopituitarism is usually dominated by the manifestations of thyroid and gonadal failure, adrenal insufficiency is a constant accompaniment and may give rise to hypoglycaemic coma. Electrolyte abnormalities and sodium depletion seldom occur as in primary adrenal insufficiency because secretion of aldosterone by the suprarenal cortex continues despite pituitary failure. 
Adrenogenital Syndrome
This syndrome, characterized by excessive adrenal secretion of androgens and high urinary I7-ketosteroid excretion, is manifest by pseudohermaphroditism in females and macrogenitosomia praecox in males. The condition is due to an enzymic defect in the adrenal cortex which prevents the normal biosynthesis of hydrocortisone, and this in turn leads to increased pituitary secretion of ACTH. Wilkins and his associates (i95i) were the first to show that the condition could be treated satisfactorily by giving cortisone, which suppressed the pituitary and caused a fall in the adrenal secretion of androgens. The treatment is controlled by inducing sufficient pituitary suppression to reduce the urinary excretion of I7-ketosteroids to a normal level for the age of the patient.
On a weight for weight basis the pituitary suppressive action of the following steroids is in the order ga-fluorohydrocortisone, prednisone, hydrocortisone and cortisone (Kupperman et al., I955) .
Al-fluorohydrocortisone is even more potent (Fig. 2) , but neither of the fluorinated compounds can be used for prolonged treatment because they so readily induce oedema and hypertension (Kupperman et al., 1955; Owen et al., I957) . Prednisone and prednisolone are more effective, weight for weight, than either cortisone or hydrocortisone orally, and being given in smaller amounts they themselves make a negligible contribution to the urinary excretion of I7-ketosteroids. If large amounts of cortisone or hydrocortisone are required, it becomes difficult to judge whether the desired degree of pituitary suppression has been --i 7une 1958 achieved because the exogenous steroid adds to the 17-ketosteroid excretion. For reasons of convenience oral treatment with prednisone or prednisolone is probably the method of choice (Spence et al., I956) , but the pituitary suppression will be more intermittent than that achieved by the less convenient intramuscular injections of cortisone or hydrocortisone. However, an intramuscular injection of microcrystalline cortisone once monthly (Prader, I953) (Jailer et al., 1954) , they contribute substantially to the urinary output of 17-ketosteroids and glucocorticoids; therefore the more potent fluorinated compounds are preferred. A daily dose of 5 to io mg. ga-fluorohydrocortisone (Cope, I956) or 2 mg. AL-fluorohydrocortisone (Fig. 2) is sufficient to cause at least temporary depression of pituitary activity.
Differentiation of Hypercakaemia
Hypercalcaemia may occur in a number of conditions and often there is difficulty in determining the underlying cause. Cortisone may be helpful in distinguishing the hypercalcaemia of hyperparathyroidism from that which occurs in a small proportion of patients with Boeck's sarcoidosis (Anderson et al., I954) . No patient with Boeck's sarcoidosis and hypercalcaemia has been reported as having a low serum inorganic phosphorus level, and this is an important point of differentiation because in hyperparathyroidism there is hypophosphataemia unless the kidneys are damaged. Furthermore, in Boeck's sarcoidosis ioo to 150 mg. cortisone a day for io days reduces the serum calcium level and increases the faecal calcium ex-cretion. A similar effect may also be observed when cortisone is given to a hypercalcaemic patient with multiple bony metastases if the steroid inhibits the growth of the neoplastic tissue. In hyperparathyroidism, on the other hand, cortisone does not influence the hypercalcaemia.
